Subsequent analysis of RNA-seq data following treatment with PX revealed significant changes in the PI3K-AKT-mTOR signaling pathway, which plays a crucial role in cell survival, proliferation, and metabolism and has been implicated in various cancers, including breast cancer [64,65,66,67]. The gene discussed is AKT1; the disease is breast carcinoma.